MDT Stock Risk & Deep Value Analysis
Medtronic PLC
Healthcare • Medical Devices
DVR Score
out of 10
The Bottom Line on MDT
We analyzed Medtronic PLC using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran MDT through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Here's what we found.
MDT Stock Risk Analysis
Overall Risk
Moderate
Financial Risk
Low
Market Risk
Medium
About Medtronic PLC (MDT)
Sector
Healthcare
Industry
Medical Devices
Market Cap Category
large
Market Cap
$130.42B
MDT Deep Value Analysis
MDT Red Flags & Warning Signs
- âš
Increased regulatory scrutiny or delays in product approvals
- âš
Major product recall or adverse event reporting
- âš
Intensified competitive pressure from innovative startups or larger rivals
Unlock MDT Red Flags & Risk Warnings
Create a free account to see the full analysis
MDT Financial Health Metrics
Market Cap
$130.42B
P/E Ratio
28.09
MDT Competitive Moat Analysis
Sign in to unlockMoat Rating
Wide
Moat Trend
Stable
Moat Sources
4 Identified
Medtronic's moat is highly durable, stemming from its vast patent estate, the complex and lengthy regulatory approval processes for medical devices, deeply entrenched relationships with healthcare providers, and the high cost/risk associated with switching critical medical equipment.
MDT Competitive Moat Analysis
Sign up to see competitive advantages
MDT Catalysts & Growth Drivers
Near-Term (0-6 months)
- •Q4 Fiscal Year 2026 Earnings Report (Estimated Early-May 2026)
- •New product launches or expanded indications in high-growth areas (e.g., diabetes, neuromodulation)
- •Positive clinical trial data for pipeline devices
Medium-Term (6-18 months)
- •Expansion into new emerging markets for key product lines
- •Strategic bolt-on acquisitions to strengthen existing segments
- •Advancements in AI/digital health integration across device platforms
Long-Term (18+ months)
- •Aging global population driving demand for medical devices
- •Increased adoption of minimally invasive surgical techniques
- •Technological advancements enabling personalized healthcare solutions
Catalysts & Growth Drivers
Upgrade to Premium to see catalysts
MDT Bull Case: What Could Go Right
- ✓
Consistent execution on R&D pipeline and new product launches
- ✓
Stable or expanding operating margins in a competitive environment
- ✓
Any signs of accelerating organic revenue growth beyond historical single-digit rates
Bull Case Analysis
See what could go right with Premium
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor.
